PMC:7321036 / 29503-29717
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T226 | 27-34 | Body_part | denotes | histone | http://purl.org/sig/ont/fma/fma74413 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T229 | 84-85 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T182 | 13-23 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T183 | 27-34 | Chemical | denotes | histone | http://purl.obolibrary.org/obo/CHEBI_15358 |
| T184 | 71-85 | Chemical | denotes | trichostatin A | http://purl.obolibrary.org/obo/CHEBI_46024 |
| T185 | 71-83 | Chemical | denotes | trichostatin | http://purl.obolibrary.org/obo/CHEBI_39146 |
| T186 | 104-114 | Chemical | denotes | bortezomib | http://purl.obolibrary.org/obo/CHEBI_52717 |
| T187 | 124-136 | Chemical | denotes | geldanamycin | http://purl.obolibrary.org/obo/CHEBI_5292 |
| T188 | 157-163 | Chemical | denotes | sodium | http://purl.obolibrary.org/obo/CHEBI_26708 |
| T189 | 174-187 | Chemical | denotes | valproic acid | http://purl.obolibrary.org/obo/CHEBI_39867 |
| T190 | 183-187 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 482 | 117-122 | Gene | denotes | Hsp90 | Gene:3320 |
| 485 | 57-66 | Chemical | denotes | scriptaid | MESH:C410733 |
| 486 | 104-114 | Chemical | denotes | bortezomib | MESH:D000069286 |
| 487 | 124-136 | Chemical | denotes | geldanamycin | MESH:C001277 |
| 488 | 157-163 | Chemical | denotes | sodium | MESH:D012964 |
| 489 | 174-187 | Chemical | denotes | valproic acid | MESH:D014635 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T192 | 0-214 | Sentence | denotes | In addition, inhibitors of histone deacetylases (HDACs) (scriptaid and trichostatin A), the proteasome (bortezomib), Hsp90 (geldanamycin), and voltage-gated sodium channels (valproic acid) were also anticorrelated. |